An Overview of Hematologic Malignancies - NCCN Educational Opportunities

Educational Events & Programs
NCCN Oncology Case Management Program™ Webinar: An Overview of Hematologic Malignancies
Friday, October 01, 2010 (On-line Webinar)
12:00 PM – 1:30 PM EDT
Register now to secure a seat at this educational activity.

Educational Objectives:

Following this program, participants should be able to:

* Summarize the appropriate testing and workup for determining risk
* Describe the risk stratification that guides treatment decisions and helps to predict outcome


Intended Audience:
This educational activity is designed to meet the needs of medical directors and other physicians, case managers, nurses, and other specialties within managed care organizations who work with cancer patients.

Presenters/Faculty:
James Foran, MD
University of Alabama at Birmingham Comprehensive Cancer Center

Accreditation:
Physicians
The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

NCCN designates this educational activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurses

This activity is approved for 1.5 contact hours. National Comprehensive Cancer Network is an approved provider of continuing nursing education by PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.
Case Managers

NCCN is accredited by the Commission for Case Manager Certification to award 1.5 clock hours to case managers for completing this program.

Supporters:

This activity is supported by an educational donation provided by Amgen. This program is supported by educational grants from: Genomic Health, Inc.; ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company; Millennium Pharmaceuticals, Inc.; Novartis Oncology; Pfizer; and sanofi-aventis.

Registration Information:
There is no registration fee for this webinar.
Register now to secure a seat at this educational activity.
NCCN Educational Opportunities